This news follows the recent ruling by the Government of India, Directorate General of Health Services, Central Drugs Standard Control Organisation that the Oska Pulse device is registered and classified as a non-invasive, pulsed electromagnetic therapy device used to decrease inflammation, increase circulation, improve mobility and relieve pain.
“In the past 12 months we’ve had a lot of interest in our products from India which has made our decision to enter the market there a relatively easy one. With the India Government’s device classification approval now formalised we look forward to bringing our drug free, non-invasive, pain management solutions to the India market.” Board Chairman Greg Battle said.
“Over many years of global health issues there has been a growing trend to alternative solutions outside opioids and traditional medical practices and as a result we are seeing greater interest in our Oska wellbeing products”. Mr Battle added.